StayWell Earns Re-accreditation From the National Committee for Quality Assurance (NCQA) for Disease Management

Share Article

Accreditation applies to StayWell programs designed to help patients manage chronic conditions

The StayWell Company announced today that it has received Patient Oriented Disease Management Accreditation from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, and diabetes programs.

Accredited status is granted to organizations that have excellent programs for the delivery and improvement of disease management and that meet or exceed NCQA’s rigorous standards.

“We deliver health solutions that are based on industry-leading research and real-life experiences,” said Dr. David Gregg, chief medical officer, StayWell. “This accreditation underscores our long-standing belief and position that comprehensive, best-practice programs can help people better manage challenging health conditions.”

For more than 40 years, StayWell has been an innovator in health promotion research, program development, and participant engagement. StayWell has remained an industry leader since the company’s founders published first-of-its-kind research identifying the link between health behaviors and health care costs, as well as the connection between health risk factors and worker productivity.

StayWell’s NCQA accreditation applies to disease management programs that are based on years of experience and research and that offer comprehensive education and intervention for patients. StayWell programs use video, print, digital, and mobile tools to educate patients about their conditions and provide detailed information about how to manage them.

Seeking NCQA accreditation is a voluntary process. Standards are developed with input from researchers in the field, the Disease Management Advisory Council (DMAC) and standing committees, employers, purchasers and providers of disease management programs, state and federal regulators, and other experts. Accreditation standards are intended to help organizations achieve the highest level of performance possible. They can also help purchasers evaluate disease management programs and improve patient care and service.

“NCQA's Disease Management Accreditation program is thorough and rigorous. It's designed to highlight only those programs that truly improve chronic care,” said NCQA President Margaret E. O’Kane.

StayWell’s accreditation is effective for three years. To learn more about the accreditation process and standards, visit ncqa.org. For more about StayWell disease management solutions, visit staywell.com.

###

About StayWell
StayWell is a health solutions company that uses the science of behavior change to help people live happier, healthier lives. StayWell brings decades of experience working across the health care industry to design solutions for improving individual and organizational health outcomes, managing the health of targeted populations, and creating brand engagement for employers and health care organizations. StayWell programs have received numerous top industry honors, including the C. Everett Koop National Health Award and the Web Health Award for health engagement programs. StayWell also has received URAC and NCQA accreditation for several of its programs. StayWell is majority-owned by Healthcare Services & Solutions, LLC, a wholly owned subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (“Merck”). The company is headquartered in Yardley, PA, and also has a major location in St. Paul, MN. To learn more, visit http://www.staywell.com.

About Merck
For over a century, Merck has been a global health care leader working to help the world be well. Merck is known as MSD outside the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, visit http://www.merck.com and connect with us on TwitterFacebookYouTube and LinkedIn.

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA
This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2016 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (http://www.sec.gov).

About NCQA
NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA accredits and certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA is committed to providing health care quality information for consumers, purchasers, health care providers and researchers.

Media contact / Barbara Tabor, APR / 651-230-9192 / barbara(at)taborPR(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Barbara Tabor
tabor PR
+1 651-230-9192
Email >